0.582

2.83% 0.016

Pre-market: .55 -0.032 -5.50%

VolitionRX Ltd (VNRX)

Overview News Price History Option Chain Discussions Forecast

VolitionRX Ltd stock is traded at $0.582, with a volume of 191.01K. It is up +2.83% in the last 24 hours and up +1.27% over the past month. VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.

Previous Close:

$0.566

Open:

$0.59

24h Volume:

191.01K

Relative Volume:

0.85

Market Cap:

$55.85M

Revenue:

$1.29M

Net Income/Loss:

$-29.87M

P/E Ratio:

-1.6167

EPS:

-0.36

Net Cash Flow:

$-14.70M

1W Performance:

-4.72%

1M Performance:

+1.27%

6M Performance:

-14.36%

1Y Performance:

-39.39%

1-Day Range:

$0.55

$0.59

1-Week Range:

$0.55

$0.6287

52-Week Range:

$0.4301

$1.02

VolitionRX Ltd Stock (VNRX) Company Profile

Name

VolitionRX Ltd

Sector

Healthcare (1169)

Industry

Diagnostics & Research (61)

Phone

646 650 1351

Address

No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX

Employee

Twitter

@VolitionRx

Next Earnings Date

2025-03-14

Latest SEC Filings

VNRX's Discussions on Twitter

Compare VNRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VNRX VolitionRX Ltd	0.582	55.85M	1.29M	-29.87M	-14.70M	-0.36
TMO Thermo Fisher Scientific Inc	508.90	191.99B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	204.09	145.87B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	117.33	33.47B	6.53B	1.26B	1.31B	4.35
IDXX Idexx Laboratories Inc	406.29	33.04B	3.90B	887.87M	798.08M	10.67
IQV Iqvia Holdings Inc	181.43	31.99B	15.41B	1.37B	2.11B	7.50

VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-01-23	Downgrade	The Benchmark Company	Buy → Hold
Feb-17-22	Resumed	Cantor Fitzgerald	Overweight
Mar-10-21	Initiated	Cantor Fitzgerald	Overweight
May-16-18	Initiated	Maxim Group	Buy
May-14-18	Reiterated	The Benchmark Company	Buy
Sep-07-16	Reiterated	Rodman & Renshaw	Buy
Feb-01-16	Initiated	Rodman & Renshaw	Buy

View All

VolitionRX Ltd Stock (VNRX) Latest News

Mar 13, 2025

VolitionRx extends Nu.Q Vet Cancer Test automation agreement with Fujifilm - TipRanks

Mar 13, 2025

Volition Signs First Ever Nu.Q Vet Cancer Test Automation Agreement With Fujifilm Vet Systems - Marketscreener.com

Mar 13, 2025

VolitionRx expands cancer test deal with Fujifilm Vet Systems By Investing.com - Investing.com South Africa

Mar 13, 2025

VolitionRx Signs Canine Cancer Test Automation Deal With Fujifilm Vet Systems -March 13, 2025 at 09:07 am EDT - Marketscreener.com

Mar 13, 2025

Volition's Game-Changing Cancer Test for Dogs Goes Automated with Fujifilm Deal - StockTitan

Mar 13, 2025

Mar 12, 2025

StockNews.com Begins Coverage on VolitionRx (NYSE:VNRX) - Defense World

Mar 12, 2025

Mar 05, 2025

VNRX: Additional clinical papers & company webinars provide insights to Volition’s progress. Nu.Q Discover biomarkers selected for clinical trial. Management continues to focus on signing licensing deals for Capture-PCR & Nu.Q NETs - Yahoo Finance

Mar 05, 2025

VolitionRx’s (VNRX) Buy Rating Reaffirmed at D. Boral Capital - Defense World

Mar 05, 2025

Mar 04, 2025

Volition's Nu.Q® Discover Biomarkers to be utilized in Human Clinical Study Sponsored by Leading Pharmaceutical Company for the First Time - Yahoo Finance

Mar 04, 2025

VolitionRx (NYSE:VNRX) Earns Sell Rating from Analysts at StockNews.com - Defense World

Mar 04, 2025

Feb 27, 2025

Analyzing IDEXX Laboratories (NASDAQ:IDXX) and VolitionRx (NYSE:VNRX) - Defense World

Feb 12, 2025

Feb 07, 2025